RxDoctor Payments Data

Aaron Hunt, PA

Medical · Holland, MINPI 1619990850

Payments from drug & device makers

$297in general payments, 2019–2025

Across 17 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacyclics LLC, An Abbvie Company$79
  • Amgen$51
  • AbbVie$30
  • Genentech USA, Inc.$24
  • Jazz Pharmaceuticals Inc.$21
  • Seagen Inc.$18
  • plus $75 from 5 others

What the payments were for

  • Food & beverage$297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$297 in reported general payments places this provider in the 40th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$39,882
Medicare patients
184
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept199$1,492,408
Humira(Cf) PenAdalimumab160$1,059,664
Orencia ClickjectAbatacept53$381,491
EnbrelEtanercept36$287,597
Cosentyx Sensoready PenSecukinumab31$275,748
Humira PenAdalimumab28$193,270
Enbrel MiniEtanercept17$161,876
OrenciaAbatacept23$141,086
Humira(Cf)Adalimumab14$122,709
Cosentyx Unoready PenSecukinumab11$81,287
ActemraTocilizumab14$68,702
Hydroxychloroquine Sulfate1,034$67,881
OtezlaApremilast13$64,327
MethotrexateMethotrexate Sodium867$31,503
Prednisone1,172$9,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel, Otezla$51$351,92349 claims
AbbVieHumira(Cf)$30$122,70914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 755 medical providers in Michigan.

Other medical in Holland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →